{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:11:13Z","timestamp":1768410673490,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.urolonc.2017.07.012","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T09:54:14Z","timestamp":1502186054000},"page":"663.e15-663.e21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Subcutaneous adipose tissue characteristics and the risk of biochemical recurrence in men with high-risk prostate cancer"],"prefix":"10.1016","volume":"35","author":[{"given":"Andrew M.","family":"McDonald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John B.","family":"Fiveash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Kirkland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rex A.","family":"Cardan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rojymon","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C.","family":"Dobelbower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eddy S.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2017.07.012_bib1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-010-0990-0","article-title":"Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis","volume":"123","author":"Protani","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.urolonc.2017.07.012_bib2","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1200\/JCO.2011.37.1260","article-title":"Prognostic impact of body mass index stratified by smoking status in patients with esophageal adenocarcinoma","volume":"29","author":"Yoon","year":"2011","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.urolonc.2017.07.012_bib3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/gut.2008.164053","article-title":"Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH","volume":"58","author":"Ohki","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.urolonc.2017.07.012_bib4","first-page":"5229","article-title":"Central adiposity as a major risk factor of ovarian cancer","volume":"29","author":"Delort","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urolonc.2017.07.012_bib5","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1200\/JCO.2016.68.4837","article-title":"Obesity and other cancers","volume":"34","author":"Yang","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2017.07.012_bib6","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1158\/1535-7163.MCT-14-0183","article-title":"Lipid catabolism via CPT1 as a therapeutic target for prostate cancer","volume":"13","author":"Schlaepfer","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.urolonc.2017.07.012_bib7","doi-asserted-by":"crossref","first-page":"42660","DOI":"10.1074\/jbc.M304984200","article-title":"Prostate cancer cell-adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase","volume":"278","author":"Onuma","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urolonc.2017.07.012_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/1477-3163.83937","article-title":"Androgen receptor signaling in prostate cancer development and progression","volume":"10","author":"Lonergan","year":"2011","journal-title":"J Carcinog"},{"key":"10.1016\/j.urolonc.2017.07.012_bib9","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1200\/JCO.2010.27.9935","article-title":"Energy balance, host-related factors, and cancer progression","volume":"28","author":"Hursting","year":"2010","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.urolonc.2017.07.012_bib10","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1158\/1940-6207.CAPR-10-0229","article-title":"Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis","volume":"4","author":"Cao","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.urolonc.2017.07.012_bib11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00345-010-0629-0","article-title":"Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer","volume":"29","author":"Kok","year":"2011","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2017.07.012_bib12","article-title":"Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database","author":"Vidal","year":"2016","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2017.07.012_bib13","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","article-title":"Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image","volume":"97","author":"Shen","year":"2004","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.urolonc.2017.07.012_bib14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/ijo.2009.279","article-title":"Association between single-slice measurements of visceral and abdominal subcutaneous adipose tissue with volumetric measurements: the Framingham Heart Study","volume":"34","author":"Irlbeck","year":"2010","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.urolonc.2017.07.012_bib15","doi-asserted-by":"crossref","first-page":"e002545","DOI":"10.1161\/JAHA.115.002545","article-title":"Cross-sectional associations of computed tomography (CT)-derived adipose tissue density and adipokines: the Framingham Heart Study","volume":"5","author":"Lee","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.urolonc.2017.07.012_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/gerona\/glt070","article-title":"Adipose tissue density, a novel biomarker predicting mortality risk in older adults","volume":"69","author":"Murphy","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.urolonc.2017.07.012_bib17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/mc.20720","article-title":"Energy balance modulates colon tumor growth: interactive roles of insulin and estrogen","volume":"50","author":"Rondini","year":"2011","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.urolonc.2017.07.012_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.6004\/jnccn.2016.0004","article-title":"Prostate cancer, version 1.2016","volume":"14","author":"Mohler","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.urolonc.2017.07.012_bib19","first-page":"1181","article-title":"Efficacy and toxicity of conventionally fractionated pelvic radiation with a hypofractionated simultaneous versus conventionally fractionated sequential boost for patients with high-risk prostate cancer","volume":"52","author":"McDonald","year":"2013"},{"key":"10.1016\/j.urolonc.2017.07.012_bib20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ijrobp.2015.05.024","article-title":"A phase 3 trial of 2 years of androgen suppression and radiation therapy with or without adjuvant chemotherapy for high-risk prostate cancer: final results of Radiation Therapy Oncology Group phase 3 randomized trial NRG Oncology RTOG 9902","volume":"93","author":"Rosenthal","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urolonc.2017.07.012_bib21","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1118\/1.1609271","article-title":"Quality assurance for computed-tomography simulators and the computed-tomography-simulation process: report of the AAPM Radiation Therapy Committee Task Group No. 66","volume":"30","author":"Mutic","year":"2003","journal-title":"Med Phys"},{"key":"10.1016\/j.urolonc.2017.07.012_bib22","first-page":"1","article-title":"Skeletal muscle mass and quality: evolution of modern measurement concepts in the context of sarcopenia","author":"Heymsfield","year":"2015","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.urolonc.2017.07.012_bib23","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urolonc.2017.07.012_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0021-9681(72)90027-6","article-title":"Indices of relative weight and obesity","volume":"25","author":"Keys","year":"1972","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.urolonc.2017.07.012_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/NT.0000000000000092","article-title":"Body mass index: obesity, BMI, and health: a critical review","volume":"50","author":"Nuttall","year":"2015","journal-title":"Nutr Today"},{"key":"10.1016\/j.urolonc.2017.07.012_bib26","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ijc.29842","article-title":"Body size across the life course and prostate cancer in the Health Professionals Follow-up Study","volume":"138","author":"Moller","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2017.07.012_bib27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/BF03347427","article-title":"The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults?","volume":"30","author":"Bahceci","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.urolonc.2017.07.012_bib28","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nri1415","article-title":"Inflammation and necrosis promote tumour growth","volume":"4","author":"Vakkila","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.urolonc.2017.07.012_bib29","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1745-7254.2008.00889.x","article-title":"Tumor necrosis factor and cancer, buddies or foes?","volume":"29","author":"Wang","year":"2008","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.urolonc.2017.07.012_bib30","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1038\/sj.bjc.6601814","article-title":"Serum levels of IL-6 and TNF-[alpha] correlate with clinicopathological features and patient survival in patients with prostate cancer","volume":"90","author":"Michalaki","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2017.07.012_bib31","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1002\/cncr.28185","article-title":"The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate","volume":"119","author":"Hall","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2017.07.012_bib32","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1464-410X.2005.05447.x","article-title":"C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer","volume":"95","author":"Lehrer","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2017.07.012_bib33","doi-asserted-by":"crossref","first-page":"789653","DOI":"10.1155\/2012\/789653","article-title":"Androgens and adipose tissue in males: a complex and reciprocal interplay","volume":"2012","author":"Mammi","year":"2012","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.urolonc.2017.07.012_bib34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/en.2004-1649","article-title":"Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors","volume":"147","author":"Singh","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.urolonc.2017.07.012_bib35","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1210\/en.2011-2111","article-title":"Androgen effects on adipose tissue architecture and function in nonhuman primates","volume":"153","author":"Varlamov","year":"2012","journal-title":"Endocrinology"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143917303575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143917303575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:11:19Z","timestamp":1761041479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143917303575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1078143917303575"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2017.07.012","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subcutaneous adipose tissue characteristics and the risk of biochemical recurrence in men with high-risk prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2017.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}